Collaboration on research & production of ExtreMESH
DSM Dyneema, the inventor and manufacturer of the world's strongest fiber, Dyneema Purity, announced a partnership with Proxy Biomedical. The alliance encourages further research and production of ExtreMESH, a durable surgical mesh made from DSM's Dyneema Purity high-performance polyethylene fiber technology.
“With new access to Proxy Biomedical's proven expertise in high performance materials research, development and manufacturing, our ability to help those needing tissue repair or regeneration is expanding,” said Carina Snijder, Business Manager for DSM's Dyneema Purity fiber. “We are always excited when we get the chance to provide Dyneema Purity fiber for new uses.”
“Proxy Biomedical is very pleased to be aligned with DSM Dyneema and to be able to offer ExtreMESH” said Peter Gingras, Managing Director of Proxy Biomedical Ltd. “We believe that our partnership will allow the development of new biomedical meshes and scaffolds where the demand for high strength, fatigue and abrasion resistance and low elongation is paralleled by the availability of virtual unlimited flexibility in mesh pore size, fiber diameter and weight.”
The partnership, which is aimed at the development by Proxy Biomedical of innovative technologies to advance orthopaedic treatments, precedes the opening of the annual Orthopaedic Research Society conference where DSM's Dyneema Purity fiber will be referenced in a clinical presentation and Proxy Biomedical is exhibiting.
ORS conference attendees are encouraged to visit Proxy Biomedical's booth, #1527 to learn more about ExtreMESH and Dyneema Purity fiber. In addition, the efficacy of cables made with Dyneema Purity fiber in fusionless posterior spinal instrumentation in an ovine model will be the subject of a clinical presentation, Poster No. 0825.
In the spirit of open innovation, DSM Dyneema actively explores licensing opportunities of its knowledge on the use and applicability of its Dyneema Purity fiber. DSM Dyneema is a trusted partner with its quality system certified to the ISO 9001 and ISO 13845 standards, providing its partners with an expertise in quality and regulatory compliance.
DSM Biomedical develops novel materials-based solutions to meet the present and future needs of the medical device and biopharmaceutical industries. Building on the expertise and strengths of DSM, the company's product portfolio includes coatings, drug delivery platforms and a wide range of biomedical materials for use in short- and long-term implantable medical devices.
Founded in 2002, Proxy Biomedical Group, located in Cleveland, Ohio and Galway, Ireland is a privately held, life science company engaged in design service and commercializing proprietary surgical mesh biomaterials for the repair and regeneration of tissue. Proxy Biomedical's proprietary surgical mesh products include MotifMesh and VitaMesh, which are FDA approved for distribution within the United States and CE marked for distribution within the European Community.
DSM Dyneema B.V.